Fentanyl transdermal system and Zide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fentanyl transdermal system (fentanyl) and Zide (hydrochlorothiazide). Common drug interactions include application site erythema among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Fentanyl transdermal system and Zide. It is created by eHealthMe based on reports of 100 people who take the same drugs from the FDA, and is updated regularly.

What is Fentanyl transdermal system?

Fentanyl transdermal system has active ingredients of fentanyl. It is often used in pain. eHealthMe is studying from 5,728 Fentanyl transdermal system users. Check the latest studies of Fentanyl transdermal system.

What is Zide?

Zide has active ingredients of hydrochlorothiazide. It is often used in high blood pressure. eHealthMe is studying from 183,246 Zide users. Check the latest studies of Zide.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 27, 2026

100 people who take Fentanyl transdermal system and Zide together, and have interactions are studied.

Fentanyl transdermal system and Zide drug interactions.

What are the common drug interactions of Fentanyl Transdermal System and Zide, by gender? *:

female:

  1. Application site erythema (redness of the skin at application site)
  2. Application site pruritus (application site severe itching of the skin)
  3. Hyperhidrosis (abnormally increased sweating)
  4. Death
  5. Muscle twitching
  6. Rash
  7. Fatigue (feeling of tiredness)
  8. Somnolence (a state of near-sleep, a strong desire for sleep)
  9. Tremor (trembling or shaking movements in one or more parts of your body)
  10. Unresponsive to stimuli

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Drug ineffective
  3. Therapeutic response decreased (less preventive response)
  4. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  5. Aspartate aminotransferase increased
  6. Asthenia (weakness)
  7. Breakthrough pain
  8. Carotid artery occlusion (artery blockage)
  9. Constipation
  10. Dehydration (dryness resulting from the removal of water)

What are the common drug interactions of Fentanyl Transdermal System and Zide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Dizziness
  2. Somnolence (a state of near-sleep, a strong desire for sleep)
  3. Unresponsive to stimuli
  4. Urine output decreased
  5. Urinary retention (the inability to completely or partially empty the bladder)
  6. Application site erythema (redness of the skin at application site)
  7. Application site pruritus (application site severe itching of the skin)
  8. Fatigue (feeling of tiredness)
  9. Nausea (feeling of having an urge to vomit)
  10. Overdose

50-59:

  1. Drug effect decreased
  2. Dyspnoea (difficult or laboured respiration)
  3. Eyelid ptosis (falling of the upper or lower eyelid)
  4. Fluid retention (an abnormal accumulation of fluid in the blood)
  5. Gamma-glutamyltransferase increased
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  7. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  8. Weight decreased
  9. Weight increased
  10. Drug effect increased

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Insomnia (sleeplessness)
  3. Asthenia (weakness)
  4. Death
  5. Drug dependence
  6. Diarrhoea
  7. Tremor (trembling or shaking movements in one or more parts of your body)
  8. Abdominal pain
  9. Fall
  10. Hypersomnia (excessive daytime sleepiness (eds))

What are the existing conditions these people have? *

  1. Back Pain: 33 people, 33.00%
  2. High Blood Cholesterol: 20 people, 20.00%
  3. Depression: 15 people, 15.00%
  4. Fluid Retention (an abnormal accumulation of fluid in the blood): 15 people, 15.00%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 11.00%
  6. Joint Pain: 11 people, 11.00%
  7. Sleep Disorder: 11 people, 11.00%
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints): 10 people, 10.00%
  9. Muscle Spasms (muscle contraction): 9 people, 9.00%
  10. Breakthrough Pain: 8 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Fentanyl transdermal system and Zide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Fentanyl transdermal system and Zide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fentanyl transdermal system:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fentanyl transdermal system and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fentanyl and hydrochlorothiazide (the active ingredients of Fentanyl transdermal system and Zide, respectively), and Fentanyl transdermal system and Zide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: